Tachyon Therapeutics
Tachyon is advancing novel first-in-class compounds against significant new drug targets for treatments against cancer.
San Francisco, United States
3 employees
Series A
Biotechnology, Health Care +1
General Information
San Francisco, United States
BounceWatch is an independent company data service, not affiliated with Tachyon Therapeutics. To contact Tachyon Therapeutics, visit tachyontx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Tachyon Therapeutics compare?
A PDF of Tachyon Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Tachyon Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Tachyon Therapeutics
No funding data available for Tachyon Therapeutics yet.
Tachyon Therapeutics Alternatives & Competitors
View All Alternatives
First-in-class ADCs tailored to attack advanced cancer
Discovering and developing targeted carcinoma therapies through innovative drug discovery and reposi...
A precision oncology company focused on small molecule therapies optimized to target key driver mech...
FAQ About Tachyon Therapeutics
Source: BounceWatch company record for Tachyon Therapeutics, https://bouncewatch.com/company/tachyon-therapeutics, updated 8 January 2025. When citing, please name BounceWatch and link this page.
